Dr. Michelle Aimee Rodriguez Coste, MD

Dr. Rodriguez Coste practices at Atrium Health Cabarrus in Concord, North Carolina, part of Advocate Health.

Dr. Rodriguez Coste's NPI, 1457498289, was assigned on January 31, 2007. Dr. Rodriguez Coste holds North Carolina license 2013-01664.

Dr. Rodriguez Coste's primary practice is Atrium Health Cabarrus, at 920 Church St N, Concord, NC 28025 in Cabarrus County. The practice phone is (704) 783-3000.

Dr. Rodriguez Coste's primary practice is Atrium Health Cabarrus in Concord, North Carolina, part of Advocate Health. Dr. Rodriguez Coste is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Rodriguez Coste to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rodriguez Coste practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Rodriguez Coste's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Rodriguez Coste is licensed in North Carolina.

CMS data shows 296 Medicare services from Dr. Rodriguez Coste across 6 procedure codes in 2024, for 143 Medicare patients. Medicare paid $22,118 for them.

CMS counts 143 Medicare patients who saw Dr. Rodriguez Coste in 2024. The largest group is 75 to 84, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rodriguez Coste's median patient age at 68, with 47% women.

In 2024, Dr. Rodriguez Coste wrote 1,310 Medicare Part D claims for 131 patients. 53% of them were for generic drugs. CMS names the drug for 1,194 of them, across 28 drugs with 11 or more claims each, at $2,098,129 in total drug cost. In 2023, CMS named 1,274 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rodriguez Coste for performance year 2024, reported as part of a group. Dr. Rodriguez Coste accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rodriguez Coste as offering telehealth.

CMS Open Payments shows 15 general payments to Dr. Rodriguez Coste from 6 drug and device companies from 2016 to 2022. Education make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $705.